Latest News and Press Releases
Want to stay updated on the latest news?
-
MOUNTAIN VIEW, Calif., June 27, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) (the "Company") today mailed a letter to stockholders advising them to protect the value of their investment in VIVUS...
-
MOUNTAIN VIEW, Calif., June 26, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) (the "Company") today announced that the European Commission (EC) has adopted the implementing decision granting...
-
Urges Stockholders Not to be Misled by Sam Colin and His Hedge Fund, First Manhattan Co. Believes FMC's Recent Letter to VIVUS Stockholders Contains Several Highly Questionable Claims Protect...
-
MOUNTAIN VIEW, Calif., June 21, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS), a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet...
-
MOUNTAIN VIEW, Calif., June 21, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS), a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet...
-
MOUNTAIN VIEW, Calif., June 19, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced positive results from a multicenter, placebo-controlled study, TA-501, designed to assess the...
-
Urges Stockholders Not to be Misled by FMC's Distracting Proxy Campaign Vote the GOLD Proxy Card Today and Support VIVUS's Highly Qualified Directors MOUNTAIN VIEW, Calif., June 19, 2013 (GLOBE...
-
MOUNTAIN VIEW, Calif., June 17, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that a review article has been published online in Expert Opinion on Drug Safety examining the...
-
VIVUS Urges Stockholders to Support the Board of Directors and Management Team at This Critical Time
MOUNTAIN VIEW, Calif., June 17, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) (the "Company") today mailed a letter to stockholders advising them to protect the value of their investment in VIVUS...
-
MOUNTAIN VIEW, Calif., June 15, 2013 (GLOBE NEWSWIRE) -- VIVUS,Inc. (Nasdaq:VVUS), a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet...